Ionis Pharmaceuticals, Inc. · 1 day ago
2026 Summer Intern | Cardiovascular and Renal Drug Discovery
Carlsbad, CA
Internship
Hybrid
Intern
$18/hr - $23/hr
Start in 2026 SummerIonis Pharmaceuticals, Inc. is a pioneer in RNA-targeted medicines, seeking a highly motivated summer intern for 2026 to join their Cardiovascular and Renal Drug Discovery team. The intern will contribute to in vitro disease model development and gain hands-on exposure to preclinical drug discovery, including training in advanced molecular and cellular biology techniques.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Learn the end-to-end workflow for generating CRISPR-engineered iPSC models of dilated cardiomyopathy (DCM) from isogenic iPSC lines
Establish and characterize monoclonal iPSC lines for DCM disease modeling using CRISPR-based genome editing
Participate in experimental design, data analysis, and scientific discussions within the project team
Prepare and present a formal presentation at the conclusion of the internship
Qualification
Required
MUST be currently enrolled in a U.S. Undergraduate and/or Graduate Degree Program and not graduating prior to the completion of the Ionis internship
MUST be able to begin internship between 06/08/25 and 08/14/26
MUST be able and willing to remain in the program through at least 08/14/26
MUST be able and willing to commit to a minimum 40-hour workweek
MUST be able and willing to work onsite at Carlsbad, CA
Preferred
Hands-on laboratory experience is a plus but not required
Benefits
Weekly stipend (for onsite interns only)
Housing/Travel assistance available for eligible, out-of-area interns
Networking and bonding social events
Company
Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases.
Founded in 1989
501-1000 employees
H1B Sponsorship
Ionis Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (8)
2024 (5)
2023 (3)
2022 (5)
2021 (5)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$2.45B2025-11-13Post Ipo Debt· $700M
2024-09-09Post Ipo Equity· $500.3M
2023-06-06Post Ipo Debt· $500M
Leadership Team
Brett P. Monia
Chief Executive Officer
Eric Bastings
Senior Vice President, Development Strategy
Recent News
Labiotech UG
2026-01-22
Business Wire
2026-01-22
Company data provided by crunchbase